Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;40(5):673-686.
doi: 10.1055/s-0039-1698404. Epub 2019 Dec 11.

Innovative ICU Solutions to Prevent and Reduce Delirium and Post-Intensive Care Unit Syndrome

Affiliations
Review

Innovative ICU Solutions to Prevent and Reduce Delirium and Post-Intensive Care Unit Syndrome

Alawi Luetz et al. Semin Respir Crit Care Med. 2019 Oct.

Abstract

Delirium, the most common form of acute brain dysfunction affecting up to 80% of intensive care unit (ICU) patients, has been shown to predict long-term cognitive impairment, one of the domains in "Post-ICU Syndrome" (PICS). The ICU environment affects several potentially modifiable risk factors for delirium, such as disorientation and disruption, of the sleep-wake cycle. Innovative solutions aim to transform standard concepts of ICU room design to limit potential stressors, and utilizing the patient care space as a treatment tool, exerting positive, therapeutic effects. The main areas affected by most architectural and interior design modifications are sound environment, light control, floor planning, and room arrangement. Implementation of corresponding solutions is challenging considering the significant medical and technical demands of ICUs. This article discusses innovative concepts and promising approaches in ICU design that may be used to prevent stress and to support the healing process of patients, potentially limiting the impact of delirium and PICS.

PubMed Disclaimer

Conflict of interest statement

Dr. Luetz reports personal fees from Hill-Rom, personal fees from Köhler Chemie, personal fees and other from Philips, outside the submitted work. In addition, Dr. Luetz has a patent 10 2014 215 211.9 pending, and a patent 10 2014 215 212.7 pending.